Search results
-
J
Encysive trading at the bottom...not for much longer
If anyone wants the full report on ENCY from today...email me at bisonventures@yahoo.com -
J
Encysive trading at the bottom...not for much longer
PUNK $12 target small excerpt from an analyst research report today.... ⢠We continue to strongly believe the market potential for Thelin in Europe is not reflected in the Companyâs current market cap of only $234 million. Based on conservative projections, we believe Thelin could be a... -
J
GILD defies me
All I know is the price they paid for myogen was ridiculous... Ambrisentan which they claim is 'best in class' they did not even do comparative studies, conducted trials with 1/3 the patients that Encysive had, and they just filed the NDA in mid- December. Good luck getting through the FDA...